An Active Surveillance, Post-Authorization Study to Characterize the Safety of Tofacitinib in Patients With Moderately to Severely Active Ulcerative Colitis in the Real-World Setting Using Data From the United Registries for Clinical Assessment and Research (UR-CARE) in the European Union (EU)
Clinical trial NCT06469424 · UNKNOWN
Trial details
- NCT number
- NCT06469424
- Sponsor
- Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2024-01-11
- Primary completion
- 2025-03-31
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.